Center-Authored Papers

Filters: Author is Montgomery, R Bruce  [Clear All Filters]
2016
Schweizer MT, Gulati R, Mostaghel EA, Nelson PS, Montgomery BR, Yu EY, Cheng HH.  2016.  Docetaxel-related toxicity in metastatic hormone-sensitive and metastatic castration-resistant prostate cancer.. Medical oncology (Northwood, London, England). 33(7):77. Abstract
2015
Cho E, Mostaghel EA, Russell KJ, Liao JJ, Konodi MA, Kurland BF, Marck BT, Matsumoto AM, Dalkin BL, Montgomery BR.  2015.  External beam radiation therapy and abiraterone in men with localized prostate cancer: safety and effect on tissue androgens.. International journal of radiation oncology, biology, physics. 92(2):236-43. Abstract
2014
Mostaghel EA, Morgan A, Zhang X, Marck BT, Xia J, Hunter-Merrill R, Gulati R, Plymate S, Vessella RL, Corey E et al..  2014.  Prostate cancer characteristics associated with response to pre-receptor targeting of the androgen axis.. PloS one. 9(10):e111545. Abstract
2012
Mostaghel EA, Solomon KR, Pelton K, Freeman MR, Montgomery BR.  2012.  Impact of circulating cholesterol levels on growth and intratumoral androgen concentration of prostate tumors.. PloS one. 7(1):e30062. Abstract
2011
Mostaghel EA, Marck BT, Plymate SR, Vessella RL, Balk S, Matsumoto AM, Nelson PS, Montgomery BR.  2011.  Resistance to CYP17A1 Inhibition with Abiraterone in Castration-Resistant Prostate Cancer: Induction of Steroidogenesis and Androgen Receptor Splice Variants.. Clinical cancer research : an official journal of the American Association for Cancer Research. 17(18):5913-25. Abstract
Wright JL, Kwon EM, Ostrander EA, Montgomery BR, Lin DW, Vessella R, Stanford JL, Mostaghel EA.  2011.  Expression of SLCO transport genes in castration-resistant prostate cancer and impact of genetic variation in SLCO1B3 and SLCO2B1 on prostate cancer outcomes.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 20(4):619-27. Abstract
2009
Wang D, Montgomery BR, Schmidt LJ, Mostaghel EA, Huang H, Nelson PS, Tindall DJ.  2009.  Reduced tumor necrosis factor receptor-associated death domain expression is associated with prostate cancer progression.. Cancer research. 69(24):9448-56. Abstract
2008
Montgomery BR, Mostaghel EA, Vessella R, Hess DL, Kalhorn TF, Higano CS, True LD, Nelson PS.  2008.  Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth.. Cancer research. 68(11):4447-54. Abstract